HEPATITIS A INACTIVATED AND HEPATITIS B

The Defense Logistics Agency awarded a delivery order under contract SPE2DX25D8022 to CARDINAL HEALTH, INC. (CAGE 00E55) for the supply of HEPATITIS A INACTIVATED AND HEPATITIS B with NSN 6505016322192. The total value of this order is $1,580.34, with delivery scheduled for July 20, 2026, to the USNS LUCY STONE T-AO 209 at MSC BATS in San Diego, California, under FOB Destination terms where the contractor assumes all freight costs. The contract is structured as a firm-fixed-price commercial item acquisition governed by FAR clauses 52.212-4 and 52.212-5, which establish standard commercial item terms including inspection and acceptance at destination by the government. The awardee has self-certified as a Small Business, Small Disadvantaged Business, and Women-Owned Small Business, though the acquisition was conducted as unrestricted. Payment is to be processed through the Defense Finance and Accounting Service in Columbus, Ohio, with invoices submitted per Block 18a instructions and processed via Electronic Data Interchange. The contract includes no option quantities or future ordering authorities, with the value reflecting solely the single line item for two units priced at $790.17 each. Packaging and marking requirements mandate identification numbers from Blocks 1 and 2 be clearly displayed in block letters on all packages, though no specific MIL-STD packaging, preservation, or barcoding standards are cited. Contract administration is managed by LISA QUINN and LORINDA FERRAIOLO as contracting officers, with Catherine Gilbert serving as a technical point of contact. The acquisition was issued under solicitation SPE2DX24R0001, which closed on March 13, 2024, and was awarded March 7, 2025, with no additional special requirements, security clearances, or OCI clauses noted in the documentation.